Articles Archives - Page 608 of 792

MondayDec 09, 2019 11:48 am

Xalles Holdings Inc. (XALL) Banks on Bullish Cryptocurrency Global Trends

Xalles entered revenue sharing relationship with automated cryptocurrency trading engine ATN Trading, enabling customers to link their Binance or Coinbase accounts to the engine to trade many currencies According to Q2 2019 results, the company has generated revenue for fifth consecutive quarters Non-cash transactions expected to top $1 trillion by 2023, as cryptocurrency systems are becoming increasingly popular Heeding expert forecasts, fintech holding company Xalles Holdings Inc. (OTC: XALL) is banking on the bullish cryptocurrency global trend as it takes steps to perfect its distribution of automated crypto trading solutions and make cryptocurrency trading more accessible. Since decentralized systems are…

MondayDec 09, 2019 11:19 am

HTC Extraction Systems (TSX.V: HTC) Reports Continued Revenue Growth in Third Quarter Results

HTC Extraction Systems is turning its distillation technology prowess toward hemp biomass refining for the cannabidiol (CBD) product market The company recently reported third quarter financial results showing a year-over-year revenue increase of more than 2.5 times largely due to agri-infrastructure operations, but expects to see new and greater growth as its CBD production takes shape The company has completed construction on a 19,000-square-foot facility near Regina, Saskatchewan that will house its quality-assurance testing and product-development laboratories as well as its extraction and formulation-processing operations HTC has also recently acquired California-based Kase Farma Inc., an extraction and formulation company in…

MondayDec 09, 2019 10:42 am

Trxade Group Inc. (TRXD) Set to Celebrate, Build on Pharmacy Services’ Growth with Investing Trade Show Appearance

Pharmaceutical services business Trxade Group Inc. continues to build on a decade’s experience in sustaining independent health care providers by expanding its revenue base and number of subscribers to its business-to-business platform The company recently reported year-over-year revenue growth of 173 percent for its third quarter Trxade Group’s financial growth is largely due to income from its acquisition of Community Specialty Pharmacy, LLC last year, and the company continues to expand its medical service opportunities and revenue base with a new online consultation feature The online consultation service will establish “health hubs” through independent pharmacies so underserved patients can consult…

FridayDec 06, 2019 3:19 pm

LiveWire Ergogenics Inc. (LVVV) Pioneers Potential Industry ‘Gold Standard’ with its 7X Pure Cannabis Compliance and Dosage Verification System

LiveWire collaborates with Basso Botanicals to launch new cannabis, cannabis/CBD dosage and verification system LVVV system improves transparency of cannabis industry by giving consumers, business, municipalities ability to verify product standards System makes it easier for growers, manufacturers and retailers to comply with increasingly strict industry requirements LiveWire Ergogenics Inc. (OTC: LVVV), a health and wellness company that has taken unique and bold steps forward in the cannabis industry, recently announced the launch of a cannabis testing and verification system that can be used to verify potency, materials of origin, dosages and more. The system is called the 7X Pure…

FridayDec 06, 2019 2:59 pm

ChineseInvestors.com Inc. (CIIX) CEO Sees Untapped Potential for CBD in China’s Market, Speaks to Stock Fluctuation

CIIX CEO Warren Wang and CBD Biotech executives attended 2019 China Industrial Cannabis CBD Industry International Conference At well over one billion people, China’s cannabis industry market potential is four times the size of America’s CEO responds to stock’s fluctuating volatility, urges shareholders to continue to invest ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading purveyor of financial information and education for Chinese-speaking investors in the United States and China providing real-time market commentary, analysis, and educational-related services in Chinese character language sets. The products and services offered help investors make informed decisions and meet individualized financial goals. After creating inroads…

FridayDec 06, 2019 2:12 pm

SRAX Inc.’s (NASDAQ: SRAX) Focus on Consumer Privacy and Control of Digital Data Ahead of Competition

SRAX BIGtoken proprietary platform based on consumers’ rights to privacy, ownership of digital data BIGtoken platform allows consumers to own and earn from their digital data SRAX offers access to valuable proprietary data from consumers who opt in SRAX Inc.’s (NASDAQ: SRAX) philosophy about the importance of consumers controlling and owning their own personal digital data has been reinforced by a YouTube video from Apple that tells consumers that their own private information on an iPhone – from personal health to text messages – should remain private. SRAX, a technology firm that permits consumers to control their own digital privacy…

FridayDec 06, 2019 11:18 am

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Unveils Full-Spectrum CBD Oil

SPRWF launches Pūr Dew, an exclusive, full-spectrum CBD oil available under company’s wellness-focused brand, Blissco New product part of company’s strategic entry into one of the fastest-growing product segments Initially available in British Columbia, new product expected in other provinces in coming months The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies, has launched its newest product – Pūr Dew, an exclusive, full-spectrum CBD oil available under the company’s wellness-focused brand, Blissco (http://ibn.fm/8DYnc). The product marks a milestone for Supreme Cannabis Company as it enters the CBD market; current SPRWF products include…

ThursdayDec 05, 2019 1:52 pm

Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Tech Primed to Play Key Role in Cancer Drug Development Efforts

Predictive Oncology subsidiary TumorGenesis developing faster, less costly, and more accurate PDx cancer models that better mimic the patient's tumor TumorGenesis revolutionary technology will provide pharmaceuticals with quicker and more effective drug development while significantly improving patient outcomes There’s an unmet need for a multi-omic approach (genome, transcriptome, epigenome, proteome, responseome, and microbiome), but such data is difficult to generate quickly. Predictive Oncology has access to historical data that competitors need at least five years to develop, which presents a multi-million-dollar market opportunity The global cancer diagnostics market was valued at $144.4 billion in 2018 and is expected to grow…

Site Search

Company Search

Category: Articles